ENA Respiratory gets grant to test nasal spray for viruses

ENA Respiratory will run an Australian trial of INNA-051. This nasal spray is designed to boost immune defences against respiratory viruses. The company is one of six biotech firms in infectious disease. They are sharing $10.48 million in federal funding. The trial starts early 2027.

Why it mattersA spray that boosts immunity against multiple respiratory viruses could cut hospital admissions and serious illness. The funding shows government backing for Australian biotech innovation.

AustraliaThis Australian-led trial may produce a new defence against respiratory viruses affecting millions. It also demonstrates federal support for homegrown biotech development.

✓ Claims checked against the source and corrected before publish. checked 5 d ago

Next in today's edition

File image: Wide view of military cemetery with rows of white headstones, trees, and cloudy sky

✓ ABC NewsPower & Policy

Headstone Project fears federal funding shortfall for forgotten WWI veterans

Federal funding for military grave markers is far below Labor's pre-election promise of $3.7 million.

Why it mattersWithout adequate funding, many veterans in unmarked graves could remain unrecognized. The cost of placing headstones requires money beyond what is available.

Anthony Albanese. A man wearing black-rimmed glasses and a navy blue suit with a light patterned tie, seated in front of a large window with green foliage and a desk lamp visible in the background.

✓ PerthNowPower & Policy

Albanese defends $560 million grant program after pork-barrelling report

A report found Labor-held seats received almost three-quarters of $560 million. It came from the government's Major and Local Community Infrastructure Program.